National Bank of Canada
AVEO

National Bank of Canada’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

National Bank of Canada’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$1K – 3002
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2760
2022
Q1 		$1K Hold
100
– – ﹤0.01% 2832
2021
Q4 		$0 Buy
+100
New +$620 ﹤0.01% 2866

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

National Bank of Canada's AVEO Position: Q3 2022 in Review

National Bank of Canada sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

National Bank of Canada first reported a position in AVEO in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 77 funds tracked by Wall St. Rank hold AVEO as of Q3 2022.

  • National Bank of Canada reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • National Bank of Canada sold 100 AVEO Pharmaceuticals, Inc. shares in Q3 2022, an estimated $1K.
  • National Bank of Canada first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2021 and held it in 3 quarters.
  • National Bank of Canada's AVEO Pharmaceuticals, Inc. position peaked at $1K in Q2 2022.
  • 77 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2022.

Based on National Bank of Canada's 13F filing for Q3 2022, filed 13 Oct 2022.